These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 1853948

  • 41. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
    Lucey JV, Butcher G, Clare AW, Dinan TG.
    Acta Psychiatr Scand; 1993 Jun; 87(6):384-8. PubMed ID: 8356888
    [Abstract] [Full Text] [Related]

  • 42. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects.
    Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL.
    Am J Psychiatry; 1997 Oct; 154(10):1430-5. PubMed ID: 9326827
    [Abstract] [Full Text] [Related]

  • 43. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects.
    Golden RN, Ekstrom D, Brown TM, Ruegg R, Evans DL, Haggerty JJ, Garbutt JC, Pedersen CA, Mason GA, Browne J.
    Am J Psychiatry; 1992 Sep; 149(9):1168-75. PubMed ID: 1323933
    [Abstract] [Full Text] [Related]

  • 44. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder.
    Coiro V, Volpi R, Marchesi C, De Ferri A, Davoli C, Caffarra P, Rossi G, Caffarri G, Davolio M, Chiodera P.
    Psychoneuroendocrinology; 1993 Sep; 18(8):551-6. PubMed ID: 8127946
    [Abstract] [Full Text] [Related]

  • 45. A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls.
    Ramasubbu R, Flint A, Brown G, Awad G, Kennedy S.
    J Affect Disord; 1999 Sep; 52(1-3):121-33. PubMed ID: 10357025
    [Abstract] [Full Text] [Related]

  • 46. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients.
    Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA.
    Am J Psychiatry; 1996 Feb; 153(2):174-82. PubMed ID: 8561196
    [Abstract] [Full Text] [Related]

  • 47. Growth hormone and other hormonal responses to clonidine in melancholic and nonmelancholic depressed subjects and controls.
    Mitchell P, Smythe G, Parker G, Wilhelm K, Brodaty H, Boyce P, Hickie I.
    Psychiatry Res; 1991 May; 37(2):179-93. PubMed ID: 1652141
    [Abstract] [Full Text] [Related]

  • 48. Growth hormone, cortisol and prolactin responses to physical exercise: higher prolactin response in depressed patients.
    Kiive E, Maaroos J, Shlik J, Tõru I, Harro J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1007-13. PubMed ID: 15380861
    [Abstract] [Full Text] [Related]

  • 49. Do noradrenergic reuptake inhibitors affect serotonergic function in depression?
    Cleare AJ, Murray RM, O'Keane V.
    Psychopharmacology (Berl); 1997 Dec; 134(4):406-10. PubMed ID: 9452184
    [Abstract] [Full Text] [Related]

  • 50. Blunted prolactin response to D-fenfluramine in post-stroke major depression.
    Morris P, Hopwood M, Maguire K, Norman T, Schweitzer I.
    J Affect Disord; 2003 Sep; 76(1-3):273-8. PubMed ID: 12943959
    [Abstract] [Full Text] [Related]

  • 51. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression.
    Cleare AJ, McGregor A, O'Keane V.
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):713-9. PubMed ID: 8736274
    [Abstract] [Full Text] [Related]

  • 52. Serotonergic function in panic disorder: endocrine responses to D-fenfluramine.
    Judd FK, Apostolopoulos M, Burrows GD, Norman TR.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):329-37. PubMed ID: 8208982
    [Abstract] [Full Text] [Related]

  • 53. Risperidone is associated with blunting of D-fenfluramine evoked serotonergic responses in schizophrenia.
    Jones H, Curtis VA, Wright PA, Lucey JV.
    Int Clin Psychopharmacol; 1998 Sep; 13(5):199-203. PubMed ID: 9817624
    [Abstract] [Full Text] [Related]

  • 54. Fenfluramine provocation of anxiety in patients with panic disorder.
    Targum SD, Marshall LE.
    Psychiatry Res; 1989 Jun; 28(3):295-306. PubMed ID: 2669003
    [Abstract] [Full Text] [Related]

  • 55. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
    Prochazka H, Sjögren M, Agren H.
    J Affect Disord; 2000 Jun; 57(1-3):201-8. PubMed ID: 10708832
    [Abstract] [Full Text] [Related]

  • 56. Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function.
    O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG.
    Br J Psychiatry; 1992 May; 160():643-6. PubMed ID: 1591573
    [Abstract] [Full Text] [Related]

  • 57. Fenfluramine and idiopathic pain: a serotonergic study in non-psychiatric patients with functional gastrointestinal disorder.
    Tanum L, Bråtveit-Johansen K, Malt UF.
    Scand J Gastroenterol; 1998 Jul; 33(7):684-90. PubMed ID: 9712230
    [Abstract] [Full Text] [Related]

  • 58. Recovery from major depression is not associated with normalization of serotonergic function.
    Flory JD, Mann JJ, Manuck SB, Muldoon MF.
    Biol Psychiatry; 1998 Mar 01; 43(5):320-6. PubMed ID: 9513746
    [Abstract] [Full Text] [Related]

  • 59. Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans.
    Monteleone P, Bortolotti F, Orazzo C, Serino I, Maj M.
    Psychoneuroendocrinology; 1997 Feb 01; 22(2):79-87. PubMed ID: 9149330
    [Abstract] [Full Text] [Related]

  • 60. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior.
    Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL.
    Arch Gen Psychiatry; 1989 Jul 01; 46(7):587-99. PubMed ID: 2735812
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.